KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 132 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $42,000 | -81.2% | 10,300 | -78.4% | 0.00% | -85.7% |
| Q1 2016 | $223,000 | -36.3% | 47,664 | -31.3% | 0.01% | -17.6% |
| Q4 2015 | $350,000 | +297.7% | 69,376 | +176.0% | 0.02% | +325.0% |
| Q3 2015 | $88,000 | -22.1% | 25,140 | +122.5% | 0.00% | 0.0% |
| Q2 2015 | $113,000 | -86.1% | 11,300 | -82.3% | 0.00% | -87.5% |
| Q1 2015 | $814,000 | +150.5% | 63,937 | +235.4% | 0.03% | +39.1% |
| Q1 2014 | $325,000 | -26.8% | 19,062 | -56.6% | 0.02% | -34.3% |
| Q3 2013 | $444,000 | – | 43,916 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $3 | 0.00% |